Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. - Wikidata - awgldk - TriplyDB

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.

http://www.wikidata.org/entity/Q35097262

about

Vaccines for women for preventing neonatal tetanus Rediscovering Pertussis Dismantling the Taboo against Vaccines in Pregnancy Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic review Maternal immunization Factors influencing innate immunity and vaccine responses in infancy Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China Pertussis: Microbiology, Disease, Treatment, and Prevention.Non-reassuring fetal status: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries.Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data Maternal pertussis immunisation: clinical gains and epidemiological legacy.The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014 Maternal immunization: opportunities for scientific advancement.Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices.Asymptomatic transmission and the resurgence of Bordetella pertussis.Knowledge and Acceptability about Adult Pertussis Immunization in Korean Women of Childbearing Age.Pertussis in young infants: a severe vaccine-preventable disease The Impact of Internal Migration on under-Five Mortality in 27 Sub-Saharan African Countries Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy.Immunization of pregnant women: Future of early infant protection.Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study.Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis.Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand.Safety of Tdap vaccine in pregnant women: an observational study.Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States.Perspectives on benefit-risk decision-making in vaccinology: Conference report.Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.Vaccines in pregnancy: The dual benefit for pregnant women and infants.Maternal and infant outcomes among women vaccinated against pertussis during pregnancy.A systematic review of ethical issues in vaccine studies involving pregnant women.Pertussis vaccination in pregnancy Impact of a multi-component antenatal vaccine promotion package on improving knowledge, attitudes and beliefs about influenza and Tdap vaccination during pregnancy.Issues in pediatric vaccine-preventable diseases in low- to middle-income countries The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam.Forecasting Epidemiological Consequences of Maternal Immunization.

P2860

Q24186560-B38622DF-5D1F-43A1-ABE9-9ABD062687A9 Q26744793-3B9B2AF1-0652-403C-9DBA-14D5A4B222A5 Q26747515-A0C56E53-7B20-41F3-9DA1-F31BED260A4A Q26779482-8E752EC5-A7CA-4E0A-A3A4-83A5DA63FCAF Q26796334-7B758A0A-5362-47A0-B855-11413E8C1E05 Q26853746-EA8C1863-71B6-4992-87DE-57FD39B8D21D Q28081917-30ECBF64-CA93-4BAB-9965-66025AD80E93 Q28552431-57CF4FB3-F638-4690-9F90-E854A7D58B9E Q30251684-B9C6CFBE-059A-46DD-948E-4D3F5BC04F8C Q30276269-3FD39680-ED3A-400F-A186-2A320C2000CE Q30380537-AB27AEB6-538D-4413-B4F8-C583407B8386 Q31115556-55B3B9EE-6581-429A-9254-9ED8E0138AF2 Q31115877-AE400400-4AC2-4018-8FF4-88D8A253B4ED Q33813965-BF36C2A2-4E78-4BD6-B972-E854115E873F Q34576732-8D337558-C9B6-45E6-8E8B-6DD229F8F04B Q34999899-CDB9176D-8177-4D31-A2D4-D75E868B6824 Q34999911-ABB70335-3246-4F95-87BF-F324F4E5BC20 Q34999915-7685B011-EDA9-4853-B548-F4F29F429CF8 Q35672136-5C267DA4-59D3-4756-A1FF-EE6D50221F90 Q35778194-9FCE92EA-7A8B-4890-B3AC-9BD75A74070F Q36097162-1BAF3657-D2EE-4864-A869-31FA7A909528 Q36175180-3929FD67-A652-465E-8EF0-ECC4EAA613CC Q36201827-BA4955F5-65CB-44CF-8071-8530D5210E29 Q36389045-0C21EEEA-C18E-4ECF-90D4-576DA8C6889F Q36472308-E47E702B-421E-4FE9-8B35-C073109B3B98 Q36676385-BABE0C50-C97B-45FB-ADDB-F6AEF41DCB21 Q36779361-9F6B3947-E9D8-4D86-98EE-D6B51AA1316C Q36818929-F708F6DD-2AA2-46C8-A99A-48D1CEBD855A Q37005179-93A2966E-8D41-42D0-86C5-641563432A51 Q37130178-A39D5B49-D4AF-46ED-B55F-28EABB379F70 Q37130723-6C0C6768-DEC6-49F3-8CB6-4196FC488696 Q37130801-558049CF-E09B-45DA-8324-A13FCBB5F698 Q37197014-340F9592-4077-4C43-BB8C-FDA4AF7D0BC7 Q37197059-A500706E-D517-417D-9984-2293DD35DCEF Q37197075-2FE7ABFC-033B-4341-8CBC-0A7F54CC14BA Q37197106-6CF247CD-F0B4-4B3B-9733-65B12EE2E1F2 Q37264972-C900C0FA-6DB5-481C-8604-1032881BF652 Q37320137-335429D1-4514-4720-8C2D-0FABCB7DE148 Q37410323-6388D359-4BF5-486C-98C9-D772D2640A5C Q37410327-9B1CD3B7-7C05-4D14-8966-C4B8C96149D0

P2860

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.

http://www.wikidata.org/entity/Q35097262

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Safety and immunogenicity of t ...... : a randomized clinical trial.

@ast

Safety and immunogenicity of t ...... : a randomized clinical trial.

@en

type

label

Safety and immunogenicity of t ...... : a randomized clinical trial.

@ast

Safety and immunogenicity of t ...... : a randomized clinical trial.

@en

prefLabel

Safety and immunogenicity of t ...... : a randomized clinical trial.

@ast

Safety and immunogenicity of t ...... : a randomized clinical trial.

@en

P1433

Q35097262-ED75F65B-84BC-4916-93AF-5987713E884D

P1476

Q35097262-2334DDAB-0690-4B45-81A1-C2362E35D822

P2093

Q35097262-1EDBBFFC-ACA4-4E6E-BAE5-F519029E97D9

Q35097262-20FBFBBF-FC9A-48F8-BE79-6DEECD7DFE2B

Q35097262-23CB6BA0-59F9-4E53-8140-473DC0C7D968

Q35097262-56FBDCE0-D302-4E6D-9961-3C98C9292728

Q35097262-7EB46798-9488-4E09-868A-6EEEB4C42A00

Q35097262-940B4078-8DA6-44F8-A601-413F8DD44E2F

Q35097262-94CF55D3-36A9-4E5C-8427-287ED88D9170

Q35097262-9F219918-0321-4153-AB64-FF816BF60A5B

Q35097262-A80DB862-7910-483A-B6E0-3C6EF1438C6A

Q35097262-AEBA9BDC-4FAE-4EF0-A6E0-AB5C29D59C89

P2860

Q35097262-1C3D8276-69B7-4D19-BF43-D168B1C9562B

Q35097262-21551AEA-D649-48D8-BBF3-9B78D5BF9791

Q35097262-2EC6D9BA-7F03-4834-A796-A85B4856B699

Q35097262-4C019CFB-0677-4C1F-ABB9-2CD559789EC6

Q35097262-51CC4C4A-188B-4ED2-9710-F8C342AECFA1

Q35097262-5F45F9BB-0C85-46CC-8BE2-6C341D945691

Q35097262-80779C34-F56B-441A-B19B-5A8114F63A4E

Q35097262-8944755E-45E9-42D4-A8CA-0AD2CB20D840

Q35097262-96178CB7-2CD5-4CD2-B070-422B1A17267C

Q35097262-9A0E3A2C-C63E-4DB7-8D9C-D03B52ED64BF

P304

Q35097262-E7C0D987-F0B3-427E-85FB-FF9D85D455A4

P31

Q35097262-6B507BAA-8EEE-46F2-824F-18DC5FEED185

P356

Q35097262-799A41B4-750A-4651-95B5-F5FB6168C1A7

P407

Q35097262-AC589949-DE67-4121-86CD-83A3F0CAB791

P433

Q35097262-10BFE897-A6B4-40BE-93D3-9F3AFAEC231F

P478

Q35097262-6A2B782B-57F1-4C0C-899C-B5B3197B9218

P577

Q35097262-56F3B412-10DC-4BDC-962E-48E266871B3C

P5875

Q35097262-1C03E7E1-A49D-4D3B-8C4A-2B06817A96F2

P698

Q35097262-55E0CFA7-E596-4452-9316-0312677D9954

P921

Q35097262-66639069-1961-4C0C-8E03-6F9896924ECE

P932

Q35097262-292117F9-0A3F-4D84-B5B6-A2637F0CFC8B

P356

P1433

Journal of the American Medical Association

P1476

Safety and immunogenicity of t ...... : a randomized clinical trial.

@en

P2093

C Mary Healy

http://www.w3.org/2001/XMLSchema#string

Carey R Petrie

http://www.w3.org/2001/XMLSchema#string

Carol J Baker

http://www.w3.org/2001/XMLSchema#string

Emmanuel B Walter

http://www.w3.org/2001/XMLSchema#string

Flor M Munoz

http://www.w3.org/2001/XMLSchema#string

Geeta K Swamy

http://www.w3.org/2001/XMLSchema#string

Hunter A Hammill

http://www.w3.org/2001/XMLSchema#string

Janet A Englund

http://www.w3.org/2001/XMLSchema#string

Jennifer Ferreira

http://www.w3.org/2001/XMLSchema#string

Johannes B Goll

http://www.w3.org/2001/XMLSchema#string

P2860

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, suppo

Effect of maternal antibodies on the infant immune response.

Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants

Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).

Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women.

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.

The protective role of maternally derived antibodies against Bordetella pertussis in young infants.

Waning protection after fifth dose of acellular pertussis vaccine in children.

P304

1760-1769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2014.3633

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

311

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262054388

http://www.w3.org/2001/XMLSchema#string

P698

24794369

http://www.w3.org/2001/XMLSchema#string

P921

P932

4333147

http://www.w3.org/2001/XMLSchema#string